Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 792509, 7 pages
http://dx.doi.org/10.1155/2015/792509
Research Article

Isolated Subclinical Hyperthyrotropinemia in Obese Children: Does Levothyroxine (LT4) Improve Weight Reduction during Combined Behavioral Therapy?

School of Medicine in Katowice, Department of Pediatrics, Pediatric Endocrinology and Diabetes, Medical University of Silesia, Medykow 16, 40-752 Katowice, Poland

Received 9 March 2015; Revised 20 June 2015; Accepted 23 June 2015

Academic Editor: Giuseppe Damante

Copyright © 2015 Pawel Matusik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. T. James, R. Leach, E. Kalamara, and M. Shayeghi, “The worldwide obesity epidemic,” Obesity Research, vol. 9, supplement 4, pp. 228S–233S, 2001. View at Google Scholar · View at Scopus
  2. T. Lobstein and M.-L. Frelut, “Prevalence of overweight among children in Europe,” Obesity Reviews, vol. 4, no. 4, pp. 195–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Wang and M. A. Beydoun, “The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis,” Epidemiologic Reviews, vol. 29, no. 1, pp. 6–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Rotondi, F. Magri, and L. Chiovato, “Thyroid and obesity: not a one-way interaction,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 2, pp. 344–346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sorisky, A. Bell, and A. Gagnon, “TSH receptor in adipose cells,” Hormone and Metabolic Research, vol. 32, no. 11-12, pp. 468–474, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. R. W. Valyasevi, D. A. Harteneck, C. M. Dutton, and R. S. Bahn, “Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2352–2358, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. F. de Luca, M. Wasniewska, G. Zirilli, T. Aversa, and T. Arrigo, “At the end of a two-year follow-up elevated TSH levels normalize or remain unchanged in most the children with subclinical hypothyroidism,” Italian Journal of Pediatrics, vol. 36, article 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. H. Dekelbab, H. A. Abou Ouf, and I. Jain, “Prevalence of elevated thyroid-stimulating hormone levels in obese children and adolescents,” Endocrine Practice, vol. 16, no. 2, pp. 187–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Eliakim, M. Barzilai, B. Wolach, and D. Nemet, “Should we treat elevated thyroid stimulating hormone levels in obese children and adolescents?” International Journal of Pediatric Obesity, vol. 1, no. 4, pp. 217–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Knudsen, P. Laurberg, L. B. Rasmussen et al., “Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4019–4024, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Michalaki, A. G. Vagenakis, A. S. Leonardou et al., “Thyroid function in humans with morbid obesity,” Thyroid, vol. 16, no. 1, pp. 73–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Pacifico, C. Anania, F. Ferraro, G. M. Andreoli, and C. Chiesa, “Thyroid function in childhood obesity and metabolic comorbidity,” Clinica Chimica Acta, vol. 413, no. 3-4, pp. 396–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Rotondi, P. Leporati, A. La Manna et al., “Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?” European Journal of Endocrinology, vol. 160, no. 3, pp. 403–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Aeberli, A. Jung, S. B. Murer et al., “During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5412–5418, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Bhowmick, G. Dasari, K. L. Levens, and K. R. Rettig, “Stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid diseases in a subgroup,” Journal of the National Medical Association, vol. 99, no. 7, pp. 773–776, 2007. View at Google Scholar · View at Scopus
  16. A. Grandone, N. Santoro, F. Coppola, P. Calabrò, L. Perrone, and E. M. del Giudice, “Thyroid function derangement and childhood obesity: an Italian experience,” BMC Endocrine Disorders, vol. 10, article 8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Marras, M. R. Casini, S. Pilia et al., “Thyroid function in obese children and adolescents,” Hormone Research in Paediatrics, vol. 73, no. 3, pp. 193–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Reinehr and W. Andler, “Thyroid hormones before and after weight loss in obesity,” Archives of Disease in Childhood, vol. 87, no. 4, pp. 320–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Reinehr, G. de Sousa, and W. Andler, “Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 3088–3091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Reinehr, A. Isa, G. de Sousa, R. Dieffenbach, and W. Andler, “Thyroid hormones and their relation to weight status,” Hormone Research, vol. 70, no. 1, pp. 51–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Shalitin, M. Yackobovitch-Gavan, and M. Phillip, “Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters,” Hormone Research, vol. 71, no. 3, pp. 155–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Stichel, D. L'allemand, and A. Grüters, “Thyroid function and obesity in children and adolescents,” Hormone Research, vol. 54, no. 1, pp. 14–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Reinehr, “Obesity and thyroid function,” Molecular and Cellular Endocrinology, vol. 316, no. 2, pp. 165–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. V. Lloyd, L. Jin, I. Tsumanuma et al., “Leptin and leptin receptor in anterior pituitary function,” Pituitary, vol. 4, no. 1-2, pp. 33–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. L. M. Seoane, E. Carro, S. Tovar, F. F. Casanueva, and C. Dieguez, “Regulation of in vivo TSH secretion by leptin,” Regulatory Peptides, vol. 92, no. 1–3, pp. 25–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Iacobellis, M. C. Ribaudo, A. Zappaterreno, C. V. Iannucci, and F. Leonetti, “Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women,” Clinical Endocrinology, vol. 62, no. 4, pp. 487–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Marzullo, A. Minocci, M. A. Tagliaferri et al., “Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 8, pp. 3965–3972, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. A. Spencer, J. G. Hollowell, M. Kazarosyan, and L. E. Braverman, “National Health and Nutrition Examination Survey III Thyroid-Stimulating Hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4236–4240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. De Onis, A. W. Onyango, E. Borghi, A. Siyam, C. Nishida, and J. Siekmann, “Development of a WHO growth reference for school-aged children and adolescents,” Bulletin of the World Health Organization, vol. 85, no. 9, pp. 660–667, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. W. Chu and L. M. Crapo, “The treatment of subclinical hypothyroidism is seldom necessary,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4591–4599, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. T. McDermott and E. C. Ridgway, “Subclinical hypothyroidism is mild thyroid failure and should be treated,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 10, pp. 4585–4590, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Wu, J. W. Flowers, F. Tudiver, J. L. Wilson, and N. Punyasavatsut, “Subclinical thyroid disorders and cognitive performance among adolescents in the United States,” BMC Pediatrics, vol. 6, article 12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. O'Grady and D. Cody, “Subclinical hypothyroidism in childhood,” Archives of Disease in Childhood, vol. 96, no. 3, pp. 280–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Radetti, M. Maselli, F. Buzi et al., “The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up,” Clinical Endocrinology, vol. 76, no. 3, pp. 394–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Wasniewska, A. Corrias, T. Aversa et al., “Comparative evaluation of therapy with l-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism,” Hormone Research in Paediatrics, vol. 77, no. 6, pp. 376–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Cetinkaya, A. T. Aslan, S. Vidinlisan, and G. Ocal, “Height improvement by L-thyroxine treatment in subclinical hypothyroidism,” Pediatrics International, vol. 45, no. 5, pp. 534–537, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. K. I. Rother, D. Zimmerman, and W. F. Schwenk, “Effect of thyroid hormone treatment on thyromegaly in children and adolescents with Hashimoto disease,” The Journal of Pediatrics, vol. 124, no. 4, pp. 599–601, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Svensson, U.-B. Ericsson, P. Nilsson et al., “Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 5, pp. 1729–1734, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. N. J. Aijaz, E. M. Flaherty, T. Preston, S. S. Bracken, A. H. Lane, and T. A. Wilson, “Neurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin,” BMC Endocrine Disorders, vol. 6, article 2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Biondi, “Thyroid and obesity: an intriguing relationship,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 8, pp. 3614–3617, 2010. View at Publisher · View at Google Scholar · View at Scopus